Pilot Study of Sunitinib Tumor Levels in Patients Not on Enzyme-Inducing Anti-Epileptic Drugs Undergoing Debulking Surgery for Recurrent Glioblastoma.
Phase of Trial: Phase 0
Latest Information Update: 11 Jul 2016
At a glance
- Drugs Sunitinib (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 06 Jul 2016 Status changed from active, no longer recruiting to completed.
- 02 Sep 2011 Planned end date changed from May 2010 to May 2012 as reported by ClinicalTrials.gov.
- 02 Sep 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.